Method for modifying the substrate specificity of glucose dehydrogenase and glucose dehydrogenase substrate specificity modifier
Low-molecular weight glucose analogs are used to modify the substrate specificity of FAD-dependent glucose dehydrogenase, addressing reactivity to non-glucose sugars and improving enzyme stability, thereby enhancing the accuracy of glucose measurement.
Patent Information
- Application Number
- JP2025027976
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-10-03
- Filing Date
- 2025-02-25
- Publication Date
- 2026-11-19
- Estimated Expiration
- 2040-03-26
AI Technical Summary
Existing glucose measurement methods using glucose dehydrogenase enzymes face issues with substrate specificity, particularly reactivity to non-glucose sugars like maltose, leading to inaccurate glucose readings and potential hypoglycemia, and enzyme stability is a concern.
The use of low-molecular weight glucose analogs as substrate specificity modifiers, such as sorbitol, D-iditol, and trehalose, to modify the reactivity of FAD-dependent glucose dehydrogenase, reducing its response to non-glucose sugars while maintaining or enhancing enzyme stability.
This approach improves the specificity of glucose measurement by minimizing interference from non-glucose sugars and enhances enzyme stability, resulting in more accurate glucose detection.
Smart Images

Figure 0007954228000001 
Figure 0007954228000002 
Figure 0007954228000003
Abstract
Description
[Technical Field]
[0001] This disclosure relates to a method for modifying the substrate specificity of glucose dehydrogenase and a glucose dehydrogenase substrate specificity modifier. [Background technology]
[0002] Glucose measurement is used for monitoring blood glucose levels in diabetic patients, among other things. Typically, glucose oxidase (also known as GOD) or glucose dehydrogenase (also known as GDH) is used to quantify glucose.
[0003] Glucose oxidase is an oxidoreductase that catalyzes the oxidation of β-D-glucose to D-glucono-1,5-lactone (gluconolactone). Glucose oxidase uses oxygen as an electron acceptor and flavin adenine dinucleotide (FAD) as a cofactor.
[0004] Glucose dehydrogenases are classified as oxidoreductases that catalyze reactions that produce gluconolactone and reduced acceptors using glucose and electron acceptors as substrates. Examples of glucose dehydrogenases include nicotinamide dinucleotide-dependent GDH, nicotinamide dinucleotide phosphate-dependent GDH, pyrroloquinoline quinone (PQQ)-dependent GDH, and FAD-dependent GDH (flavin-bound GDH).
[0005] When measuring blood glucose using an enzyme that uses glucose as a substrate, the substrate specificity of the enzyme can be a problem. In particular, reactivity to maltose has sometimes been a problem. For example, wild-type PQQ-GDH is not glucose-specific and reacts with other sugars such as maltose, galactose, and xylose. Non-patent document 1 describes a problem in glucose measurement using PQQ-GDH where an inflated glucose value is obtained due to maltose and other substances present in the system, which can cause hypoglycemia. Therefore, in glucose measurement using enzymes, there has been a need for a measurement reagent that has high specificity to glucose and low reactivity to other sugars such as maltose.
[0006] To enhance substrate specificity for glucose or reduce reactivity for maltose, approaches have been attempted to search for glucose dehydrogenases (GDHs) with superior substrate specificity, and various FAD-dependent GDHs have been discovered (see Non-Patent Documents 2 and 3). Furthermore, approaches have been attempted to modify substrate specificity by obtaining the genes of isolated GDHs and genetically modifying them.
[0007] On the other hand, apart from specificity for glucose, enzyme stability can sometimes be an issue. Patent document 1 (JP 2015-139376) describes a method for improving the stability of glucose dehydrogenase by adding the mineral smectite.
[0008] Patent Document 2 (International Publication No. 2005 / 054840) aims to provide a method for measuring blood components, a sensor, and an apparatus for using the same, which can sufficiently and accurately correct the amount of blood components by measuring hematocrit values with high accuracy and reliability, and describes an apparatus that includes glucose dehydrogenase. Paragraph 0027 lists sugar alcohols as enzyme stabilizers, and states that maltitol is preferred. Maltitol is also used in the examples.
[0009] Patent document 3 (JP 2005-114359 A) aims to provide a method and sensor for measuring components without requiring complex correction steps, and describes a method for measuring glucose in blood and a sensor used therefor. Paragraph 0016 lists sugar alcohols as enzyme stabilizers, and states that maltitol is preferred. Maltitol is used in the examples.
[0010] Patent Document 4 (International Publication No. 2001 / 025776) describes a glucose sensor using PQQ-GDH. Page 8 states that a stabilizer may be added to the reaction layer of the biosensor, and discloses sugars as stabilizers. Sugars are listed, and glucose and maltose are mentioned. There is no mention of using sugars as stabilizers in the examples.
[0011] Patent document 5 (JP 2009-195250) describes a method for improving the stability of a composition containing soluble glucose dehydrogenase, and describes a composition containing a recombinant FAD-GDH derived from Aspergillus oryzae or Aspergillus tereus and trehalose.
[0012] Patent document 6 (JP 2014-018096) describes a method for improving the stability of a composition containing flavin-bound glucose dehydrogenase. [Prior art documents] [Patent Documents]
[0013] [Patent Document 1] Japanese Patent Publication No. 2015-139376 (Patent No. 6402887) [Patent Document 2] International Publication No. 2005 / 054840 Pamphlet [Patent Document 3] Japanese Patent Publication No. 2005-114359 [Patent Document 4] International Publication No. 2001 / 025776 Pamphlet [Patent Document 5] JP 2009-195250 A (Patent No. 5176045)
Patent Document 6
Non-Patent Document
[0014]
Non-Patent Document 1
Non-Patent Document 2
Non-Patent Document 3
Summary of the Invention
Problem to be Solved by the Invention
[0015] The present disclosure aims to provide a method for modifying the substrate specificity of FAD-dependent glucose dehydrogenase by using a low-molecular compound that is a glucose analog, and a glucose dehydrogenase substrate specificity modifier that is a low-molecular compound and a glucose analog.
Means for Solving the Problem
[0016] In view of the above problems, the inventors diligently investigated methods to modify the reaction to non-glucose sugars such as maltose, using approaches other than those for searching for novel GDH enzymes or for modifying the substrate specificity of existing GDH enzymes by introducing mutations. As a result, they surprisingly discovered that a small molecule compound that is a specific glucose analog modifies the reactivity of FAD-dependent glucose dehydrogenase to non-glucose sugars (e.g., maltose), thus completing the present invention.
[0017] In other words, this disclosure includes the following embodiments. [1] A method for modifying the substrate specificity of glucose dehydrogenase by using a glucose dehydrogenase substrate specificity modifier, which is a glucose analog and a small molecule compound, comprising coexisting the glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase when measuring glucose using FAD-dependent glucose dehydrogenase (FAD-GDH), wherein the ratio of the reactivity of the glucose dehydrogenase to maltose (Mal) to the reactivity of glucose (Glu) (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of the glucose dehydrogenase to maltose (Mal) to the reactivity of glucose (Glu) (Mal / Glu) in the absence of the modifier. [2] The method according to Embodiment 1, wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, D-glucar, ribitol, L-growth, trehalose, D-mannitol, xylitol, and glycerol. [3] The method according to Embodiment 1 or 2, wherein the glucose dehydrogenase is a glucose dehydrogenase derived from the genus Mucor or Aspergillus. [4] The method according to any one of embodiments 1 to 3, wherein glucose dehydrogenase is immobilized on a solid surface. [5] The method according to any one of embodiments 1 to 3, wherein glucose dehydrogenase is not immobilized on the solid surface. [6] A glucose dehydrogenase substrate specificity modifier, wherein the modifier is a low molecular weight compound that is an analog of glucose, and the ratio of the reactivity of FAD-dependent glucose dehydrogenase (FAD-GDH) to glucose (Glu) (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of FAD-GDH to glucose (Glu) (Mal / Glu) in the absence of the modifier. [7] The modifier according to Embodiment 6, wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, D-glucar, ribitol, L-growth, trehalose, D-mannitol, xylitol, and glycerol. [8] The modifier according to Embodiment 6, wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, D-glucar, ribitol, L-growth, D-mannitol, and glycerol. [9] The modifier according to any one of embodiments 6 to 8, wherein the glucose dehydrogenase is a glucose dehydrogenase derived from the genus Mucor or Aspergillus.
[10] A glucose measurement system comprising a glucose dehydrogenase substrate specificity modifier according to any one of embodiments 6 to 9 and glucose dehydrogenase immobilized on a solid surface.
[11] A glucose measurement system comprising a glucose dehydrogenase substrate specificity modifier according to any one of embodiments 6 to 9 and glucose dehydrogenase not immobilized on a solid surface.
[12] A glucose measurement composition or glucose measurement reagent comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase according to any one of embodiments 6 to 9.
[13] The glucose measurement composition or glucose measurement reagent according to Embodiment 12, comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase as separate reagents.
[14] The glucose measurement composition or glucose measurement reagent according to Embodiment 12, comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase in the same reagent.
[15] A method for measuring glucose using a modifier described in any of Embodiments 6 to 9, a system described in Embodiment 10 or 11, or a composition or reagent described in any of Embodiments 12 to 14.
[16] A method for screening glucose dehydrogenase substrate specificity modifiers, comprising the following steps: i) Steps to prepare glucose dehydrogenase, ii) A step of determining the ratio (Mal / Glu) of the reactivity of the glucose dehydrogenase to maltose (Mal) and to glucose (Glu), iii) A step of contacting the glucose dehydrogenase described in i) with a candidate substance which is a low molecular weight compound that is an analog of glucose, and then determining the ratio (Mal / Glu) of the reactivity of the glucose dehydrogenase to maltose (Mal) to glucose (Glu) in the presence of the candidate substance. iv) A step of comparing the ratio (Mal / Glu) in ii) above with the ratio (Mal / Glu) in the presence of the candidate substance in iii), and v) If the ratio (Mal / Glu) in the presence of the candidate substance in iii) is modified compared to the ratio (Mal / Glu) in ii), the step of using the candidate substance as a glucose dehydrogenase substrate specificity modifier.
[17] A method for producing a glucose measuring reagent or glucose measuring composition, comprising incorporating a glucose dehydrogenase substrate specificity modifier identified by the method of Embodiment 16 into the glucose measuring reagent or glucose measuring composition.
[18] A glucose measurement reagent comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase identified by the method of Embodiment 16.
[19] An electrode comprising a glucose dehydrogenase substrate specificity modifier and FAD-dependent glucose dehydrogenase (FAD-GDH), wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, D-glucar, ribitol, L-growth, trehalose, D-mannitol, xylitol, and glycerol.
[20] A battery comprising a glucose dehydrogenase substrate specificity modifier and FAD-dependent glucose dehydrogenase (FAD-GDH), wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, D-glucar, ribitol, L-growth, trehalose, D-mannitol, xylitol, and glycerol. This specification includes the disclosures of Japanese Patent Application No. 2019-058223 and Japanese Patent Application No. 2019-182592, which form the basis of the priority claim of this application. [Effects of the Invention]
[0018] This disclosure makes it possible to modify the substrate specificity of glucose dehydrogenase. [Modes for carrying out the invention]
[0019] In one embodiment, the present disclosure provides a glucose dehydrogenase substrate specificity modifier. The substrate specificity modifier of the present disclosure may be a glucose analog. In this specification, a glucose analog means a sugar compound or sugar alcohol compound that has a chemical structure similar to glucose but is not recognized as a substrate by glucose dehydrogenase. Glucose analogs may be low molecular weight compounds. Here, a low molecular weight compound means a compound with a molecular weight (g / mol) of about 90 to about 380, for example, a compound with a molecular weight of about 150 to about 380. Furthermore, "not recognized as a substrate by glucose dehydrogenase" means that it is not recognized as a substrate at all, or substantially not recognized as a substrate, by glucose dehydrogenase. Specifically, "not being recognized as a substrate" means that, if the activity (reactivity) with glucose as a substrate is considered 100%, the activity with respect to the glucose analog is 1% or less, 0.5% or less, 0.1% or less, 0.05% or less, 0.01% or less, 0.005% or less, 0.001% or less, for example, 0.0005% or less.
[0020] In one embodiment, the glucose dehydrogenase substrate specificity modifier of the present disclosure comprises L-growth, D-iditol, L-iditol, sorbitol, ribitol (CAS no. 488-81-3, also known as adonitol), trehalose, and D-glucar, as well as one or more compounds selected from the group consisting of D-mannitol, xylitol, and glycerol. In another embodiment, the substrate specificity modifier of the present disclosure is L-growth, D-iditol, L-iditol, sorbitol, ribitol, trehalose, D-glucar, D-mannitol, xylitol, glycerol, or one or more combinations thereof.
[0021] If the substrate specificity modifier of this disclosure contains L-growth (CAS No. 6027-89-0), it may be provided as a mixture of the L-isomer and D-isomer, for example, as a racemic mixture, or as the L-isomer. In this specification, for an optically active compound, the L-isomer means that the L-isomer exists with an optical purity of, for example, 90-100% ee, for example, 95-100% ee, for example, 97-100% ee. For example, L-growth may have an optical purity of 90-100% ee, for example, 95-100% ee, for example, 97-100% ee.
[0022] When the substrate specificity modifier of this disclosure includes D-iditol (CAS no. 25878-23-3), it is preferably provided as the D-isomer. In this specification, for an optically active compound, the D-isomer means that the D-isomer exists with an optical purity of, for example, 90-100% ee, for example, 95-100% ee, or for example, 97-100% ee. For example, D-iditol may have an optical purity of 90-100% ee, for example, 95-100% ee, or for example, 97-100% ee.
[0023] If the substrate specificity modifier of this disclosure contains L-iditol (CAS no. 488-45-9), it is preferably provided as the L-isomer. For example, the L-iditol may have an optical purity of 90-100% ee, e.g., 95-100% ee, e.g., 97-100% ee.
[0024] If the substrate specificity modifier of this disclosure includes D-glucar (CAS no. 13265-84-4), it is preferably provided as the D-isomer. For example, D-glucar may have an optical purity of 90-100%ee, e.g., 95-100%ee, e.g., 97-100%ee.
[0025] If the substrate specificity modifier of this disclosure contains D-mannitol (CAS no. 69-65-8), it is preferably provided as the D-isomer. For example, the D-mannitol may have an optical purity of 90-100%ee, e.g., 95-100%ee, e.g., 97-100%ee.
[0026] In one embodiment, the glucose dehydrogenase substrate specificity modifier of the present disclosure does not contain smectite.
[0027] The glucose dehydrogenase substrate specificity modifier of this disclosure can be incorporated into glucose measurement reagents or glucose measurement compositions such that the final concentration in the measurement solution during glucose measurement is 0.1 mM to 1000 mM, for example, 0.1 mM to 500 mM, 0.1 mM to 300 mM, 0.1 mM to 100 mM, 0.1 mM to 80 mM, 0.1 mM to 70 mM, 0.1 mM to 60 mM, 0.1 mM to 50 mM, 0.2 mM to 20 mM, 0.25 mM to 10 mM, for example, 5 mM. In one embodiment, an aqueous solution containing the glucose dehydrogenase substrate specificity modifier of this disclosure and glucose dehydrogenase can be coated onto an electrode and dried. In this case, it is expected that the glucose dehydrogenase substrate specificity modifier will be concentrated during drying, resulting in a higher concentration than the final concentration before drying. This disclosure also includes glucose dehydrogenase substrate specificity modifiers at high concentrations after drying, and electrodes coated with the modifier.
[0028] In one embodiment, the disclosure provides a glucose measurement composition or glucose measurement reagent comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase. In one embodiment, the glucose measurement reagent may be in solution form or dry form. In one embodiment, the glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase in the glucose measurement reagent may be included as separate reagents. In another embodiment, the glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase in the glucose measurement reagent may be included in the same reagent. In a further embodiment, the glucose measurement reagent does not contain glucose dehydrogenase, in which case glucose dehydrogenase may be added to the measurement solution at the time of glucose measurement. In another embodiment, the glucose measurement reagent does not contain glucose dehydrogenase substrate specificity modifier, in which case glucose dehydrogenase substrate specificity modifier may be added to the measurement solution at the time of glucose measurement.
[0029] In one embodiment, this disclosure provides a glucose measurement method using the substrate specificity modifier and glucose dehydrogenase. The glucose measurement method may be a method for measuring the concentration of glucose. The glucose measurement method may be a method for quantifying the concentration of glucose. The sample to be measured may contain glucose. The sample to be measured may contain maltose. The glucose dehydrogenase substrate specificity modifier may be included in the glucose measurement reagent beforehand, or may be added to the measurement solution at the time of glucose measurement.
[0030] In the glucose measurement method of this disclosure, the glucose dehydrogenase substrate specificity modifier may be included in the measurement solution at a final concentration of 0.1 mM to 1000 mM, for example, 0.1 mM to 500 mM, 0.1 mM to 300 mM, 0.1 mM to 100 mM, 0.1 mM to 80 mM, 0.1 mM to 70 mM, 0.1 mM to 60 mM, 0.1 mM to 50 mM, 0.2 mM to 20 mM, 0.25 mM to 10 mM, for example, 5 mM, at the time of measurement.
[0031] In one embodiment, the glucose measurement method of this disclosure may include the glucose dehydrogenase substrate specificity modifier in the glucose measurement solution. In this case, glucose dehydrogenase and the sample may be added to the glucose measurement solution to start the measurement. Alternatively, glucose dehydrogenase may be immobilized on an electrode, and the glucose measurement solution and sample may be brought into contact with the electrode to perform glucose measurement.
[0032] In another embodiment, the glucose dehydrogenase substrate specificity modifier of this disclosure may be included in the glucose measurement reagent beforehand. This measurement reagent may or may not contain glucose dehydrogenase. If the measurement reagent contains glucose dehydrogenase, the sample can be added thereto to start glucose measurement. If the measurement reagent does not contain glucose dehydrogenase, the sample and glucose dehydrogenase can be added thereto (in any order) to start glucose measurement. Alternatively, glucose dehydrogenase may be immobilized on an electrode, and the measurement reagent and sample may be brought into contact with the electrode to perform glucose measurement.
[0033] In this specification, unless otherwise specified, glucose dehydrogenase refers to FAD-dependent glucose dehydrogenase (FAD-GDH). Known FAD-GDH can be used as the glucose dehydrogenase. Suitable examples of microorganisms from which known FAD-GDH are derived include microorganisms classified in the subphylum Mucor, preferably the class Mucori, more preferably the order Mucorales, and even more preferably the family Mucoriaceae. Specifically, examples include FAD-GDH derived from the genera Mucor, Absidia, Actinomucor, and Circinella.
[0034] Microorganisms classified under the genus Mucor, with specific examples of preferred microorganisms, include Mucor prainii, Mucor javanicus, Mucor circinelloides f. circinelloides, Mucor guilliermondii, Mucor hiemalis f. silvaticus, Mucor subtilissimus, and Mucor dimorphosporus. More specifically, examples include Mucor prainii, Mucor javanicus, Mucor circinelloides f. circinelloides, Mucor guilliermondii NBRC9403, Mucor hiemalis, Mucor hiemalis f. silvaticus NBRC6754, Mucor subtilissimus NBRC6338, Mucor RD056860, and Mucor dimorphosporus NBRC5395. Examples of preferred microorganisms belonging to the genus Absidia include Absidia cylindrospora and Absidia hyalospora. Examples of preferred microorganisms belonging to the genus Actinomucor include Actinomucor elegans. Examples of preferred microorganisms belonging to the genus Circinella include Circinella minor, Circinella mucoroides, Circinella muscae, Circinella rigida, Circinella simplex, and Circinella umbellata.More specifically, examples include Circinella minor NBRC6448, Circinella mucoroides NBRC4453, Circinella muscae NBRC6410, Circinella rigida NBRC6411, Circinella simplex NBRC6412, Circinella umbellata NBRC4452, Circinella umbellata NBRC5842, Circinella RD055423, and Circinella RD055422. Note that the NBRC and RD strains are stocked strains of the NBRC (National Institute of Technology and Evaluation Biotechnology Center). These FAD-GDH strains also include their variants.
[0035] Other known FAD-GDHs include those derived from the Aspergillus genus, such as GDH from Aspergillus oryzae, GDH from Aspergillus awamori, GDH from Aspergillus aureus, GDH from Aspergillus niger, GDH from Aspergillus foetidus, GDH from Aspergillus iizkae, GDH from Aspergillus bargicolor, GDH from Aspergillus phoenix, GDH from Aspergillus bisporus, GDH from Aspergillus brunneo-uniseriatus, GDH from Aspergillus carneus, GDH from Aspergillus malignus, and GDH from Aspergillus tereus. These FAD-GDHs also include their variants.
[0036] Other known FAD-GDHs include those derived from the genus Glomerella, such as GDH from Glomerella fructigena (e.g., GDH from Glomerella fructigena strain NBRC5951), GDH from Glomerella cingulata (e.g., GDH from Glomerella cingulata strain NBRC107000), FAD-GDHs derived from the genus Colletotrichum, such as GDH from Colletotrichum gloeosporioides, Colletotrichum chlorophyti, and Colletotrichum orbiculare, and FAD-GDHs derived from the genus Botryosphaeria, such as GDH from Botryosphaeria parva. Additionally, FAD-GDHs derived from the genus Burkholderia include the membrane protein GDH from Burkhorderia cepacia and GDH from Burkhorderia cepacia strain KS1. See, for example, JP 2019-000020 (Patent No. 6453385), International Publication No. 2017 / 002896, International Publication No. 2002 / 036779 (Patent No. 4107386), etc. These FAD-GDH include their variants.
[0037] (Obtaining the gene encoding FAD-GDH) The gene encoding FAD-GDH can be obtained by genetic engineering techniques. To obtain the FAD-GDH gene, commonly used gene cloning methods can be employed. For example, chromosomal DNA or mRNA can be extracted from known microorganisms or various cells capable of producing FAD-GDH using conventional methods, such as those described in *Current Protocols in Molecular Biology* (WILEY Interscience, 1989). Furthermore, cDNA can be synthesized using the mRNA as a template. A library of chromosomal DNA or cDNA can then be constructed using the chromosomal DNA or cDNA obtained in this manner.
[0038] Next, based on known amino acid sequence information of FAD-GDH, a suitable probe DNA can be synthesized and used to select a FAD-GDH gene with high substrate specificity from a library of chromosomal DNA or cDNA. Alternatively, a suitable primer DNA can be prepared based on the above amino acid sequence, and DNA containing the target gene fragment encoding FAD-GDH with high substrate specificity can be amplified by a suitable polymerase chain reaction (PCR) such as the 5'RACE method or the 3'RACE method. These DNA fragments can then be ligated to obtain DNA containing the full length of the target FAD-GDH gene.
[0039] A method can be employed in which mutations are introduced into the acquired FAD-GDH gene, and selection is performed based on the enzymatic properties of the FAD-GDH expressed from various mutant genes.
[0040] The mutation treatment of the starting material, the FAD-GDH gene, can be carried out by any known method depending on the desired mutation type. Specifically, methods such as contacting and acting on the FAD-GDH gene or recombinant DNA incorporating the gene with a mutagenic drug; ultraviolet irradiation; genetic engineering techniques; or protein engineering techniques can be widely used.
[0041] Examples of mutagenic drugs used in the above-mentioned mutagenesis treatment include hydroxylamine, N-methyl-N'-nitro-N-nitrosoguanidine, nitrite, sulfite, hydrazine, formic acid, or 5-bromouracil.
[0042] The conditions for this contact and reaction can be adjusted according to the type of drug used, and are not particularly limited as long as the desired mutation can be induced in the FAD-GDH gene. Typically, the desired mutation can be induced by contact and reaction for 10 minutes or more, preferably 10 to 180 minutes, at a drug concentration of 0.5 to 12 M and a reaction temperature of 20 to 80°C. Even when ultraviolet irradiation is performed, it can be carried out according to the conventional method as described above (Modern Chemistry, pp. 24-30, June 1989).
[0043] As a method utilizing protein engineering techniques, techniques generally known as site-specific mutagenesis can be used. Examples include the Kramer method (Nucleic Acids Res., 12, 9441 (1984): Methods Enzymol., 154, 350 (1987): Gene, 37, 73 (1985)), the Eckstein method (Nucleic Acids Res., 13, 8749 (1985): Nucleic Acids Res., 13, 8765 (1985): Nucleic Acids Res, 14, 9679 (1986)), and the Kunkel method (Proc. Natl. Acid. Sci. USA, 82, 488 (1985): Methods Enzymol., 154, 367 (1987)). Specific methods for transforming the base sequence in DNA include the use of commercially available kits (such as the Transformer Mutagenesis Kit from Clonetech, the EXOIII / Mung Bean Deletion Kit from Stratagene, and the Quick Change Site Directed Mutagenesis Kit from Stratagene).
[0044] Alternatively, a technique known as the general polymerase chain reaction can be used (Technique, 1, 11 (1989)). In addition to the gene modification methods described above, the desired FAD-GDH gene can also be synthesized directly by organic synthesis or enzymatic synthesis.
[0045] When determining or confirming the DNA base sequence of the FAD-GDH gene selected by any of the above methods, for example, a multi-capillary DNA analysis system such as the CEQ2000 (manufactured by Beckman Coulter) can be used.
[0046] (Vector with inserted FAD-GDH gene and host cell) The FAD-GDH gene obtained as described above can be incorporated into a vector such as a bacteriophage, cosmid, or plasmid used for the transformation of prokaryotic or eukaryotic cells by conventional methods, and the host cells corresponding to each vector can be transformed or transduced by conventional methods.
[0047] Examples of prokaryotic host cells include microorganisms belonging to the genus Escherichia, such as Escherichia coli strain K-12, Escherichia corei BL21(DE3), Escherichia corei JM109, Escherichia corei DH5α, Escherichia corei W3110, and Escherichia corei C600 (all manufactured by Takara Bio). These are transformed or transduced to obtain host cells into which DNA has been introduced (transformed organisms). As a method for transferring the recombinant vector into these host cells, for example, when the host cell is a microorganism belonging to Escherichia corei, a method of transferring recombinant DNA in the presence of calcium ions can be employed, or electroporation may be used. Furthermore, commercially available competent cells (e.g., ECOS Competent Escherichia corei BL21(DE3); manufactured by Nippon Gene) may also be used.
[0048] Yeast is an example of a eukaryotic host cell. Examples of microorganisms classified as yeast include yeasts belonging to the genera Zygosaccharomyces, Saccharomyces, Pichia, and Candida. The inserted gene may include a marker gene to enable the selection of transformed cells. Examples of marker genes include genes that complement the host's nutritional requirements, such as URA3 and TRP1. Furthermore, it is desirable that the inserted gene includes a promoter or other regulatory sequence (e.g., enhancer sequence, terminator sequence, polyadenylation sequence, etc.) that can express the target gene in the host cell. Specific examples of promoters include the GAL1 promoter and the ADH1 promoter. As a method for transforming yeast, known methods such as the lithium acetate method (MethodsMol. Cell. Biol., 5, 255-269 (1995)) and electroporation (J Microbiol Methods 55 (2003) 481-484) can be suitably used, but are not limited to these. Transformation can be carried out using any method, including the spheroplast method and the glass bead method.
[0049] Furthermore, other examples of eukaryotic host cells include fungal cells such as those of the genera Aspergillus and Tricoderma. The method for producing transformants of fungal cells is not particularly limited, and one example is to insert a gene encoding FAD-GDH into a host filamentous fungus in a manner that expresses the gene, according to a conventional method. Specifically, a DNA construct is prepared by inserting the gene encoding FAD-GDH between an expression-inducing promoter and a terminator, and then the host filamentous fungus is transformed with the DNA construct containing the gene encoding FAD-GDH to obtain a transformant that overexpresses the gene encoding FAD-GDH. In this specification, a DNA fragment consisting of an expression-inducing promoter, a gene encoding FAD-GDH, and a terminator, and a recombinant vector containing said DNA fragment, prepared for transforming a host filamentous fungus, are collectively referred to as a DNA construct.
[0050] The method for inserting the gene encoding FAD-GDH into a host filamentous fungus in a manner in which it is expressed is not particularly limited, but examples include methods of direct insertion onto the chromosome of the host organism using homologous recombination, and methods of introduction into the host filamentous fungus by ligating it onto a plasmid vector.
[0051] In methods utilizing homologous recombination, a DNA construct can be ligated between sequences homologous to the upstream and downstream regions of a recombination site on a chromosome and inserted into the genome of the host fungus. By overexpressing this construct within the host fungus under the control of its own high-expression promoter, a transformant can be obtained through self-cloning. The high-expression promoter is not particularly limited, but examples include the promoter region of the translation elongation factor TEF1 gene (tef1), the promoter region of the α-amylase gene (amy), and the promoter region of the alkaline protease gene (alp).
[0052] In the vector-based method, a DNA construct can be incorporated into a plasmid vector used for filamentous fungal transformation using a standard method, and the corresponding host filamentous fungus can then be transformed using a standard method.
[0053] Suitable vector-host systems are not particularly limited as long as they are capable of producing FAD-GDH in the host filamentous fungus, and examples include the pUC19 and filamentous fungus system, and the pSTA14 (Mol. Gen. Genet. 218, 99-104, 1989) and filamentous fungus system.
[0054] While it is preferable to introduce the DNA construct into the chromosome of the host filamentous fungus, another method is to incorporate the DNA construct into an autonomously replicating vector (Ozeki et al. Biosci. Biotechnol. Biochem. 59, 1133 (1995)), thereby allowing it to be used without being introduced into the chromosome.
[0055] The DNA construct may include marker genes to enable the selection of transformed cells. The marker genes are not particularly limited and include, for example, genes that complement the host's nutritional requirements, such as pyrG, niaD, and adeA; and drug resistance genes to drugs such as pyrithiamine and hygromycin B oligomycin. The DNA construct also preferably includes promoters, terminators, and other regulatory sequences (e.g., enhancers, polyadenylation sequences) that enable the overexpression of the gene encoding FAD-GDH in the host cell. The promoters are not particularly limited but include appropriate inductive and constitutive promoters, such as the tef1 promoter, alp promoter, and amy promoter. The terminators are also not particularly limited but include, for example, the alp terminator, amy terminator, and tef1 terminator.
[0056] In a DNA construct, the expression regulatory sequence of the gene encoding FAD-GDH is not necessarily required if the DNA fragment containing the FAD-GDH gene to be inserted contains a sequence with expression regulatory function. Furthermore, when transformation is performed using cotransformation, the DNA construct may not need to contain a marker gene.
[0057] One embodiment of the DNA construct is, for example, a DNA construct in which the tef1 gene promoter, the gene encoding FAD-GDH, the alp gene terminator, and the pyrG marker gene are ligated to the In-Fusion Cloning Site in the multi-cloning site of pUC19.
[0058] As a method for transforming filamentous fungi, a method known to those skilled in the art can be appropriately selected. For example, after preparing protoplasts of the host filamentous fungus, the protoplast PEG method using polyethylene glycol and calcium chloride can be used (see, for example, Mol. Gen. Genet. 218, 99-104, 1989, Japanese Patent Publication No. 2007-222055). The culture medium for regenerating the transformed filamentous fungus should be appropriate depending on the host filamentous fungus and the transformation marker gene used. For example, if Aspergillus soybean is used as the host filamentous fungus and the pyrG gene is used as the transformation marker gene, the regeneration of the transformed filamentous fungus can be carried out, for example, in Czapek-Dox minimal medium (DIFCO) containing 0.5% agar and 1.2M sorbitol.
[0059] Furthermore, for example, in order to obtain a transformed filamentous fungus, homologous recombination may be used to replace the promoter of the gene encoding FAD-GDH, which is originally present on the chromosome of the host filamentous fungus, with a high-expression promoter such as tef1. In this case as well, it is preferable to insert a transformation marker gene such as pyrG in addition to the high-expression promoter. For example, for this purpose, referring to Example 1 and Figure 1 described in Japanese Patent Application Publication No. 2011-239681, a transformation cassette consisting of the upstream region of the gene encoding FAD-GDH - transformation marker gene - high-expression promoter - all or part of the gene encoding FAD-GDH can be used. In this case, the upstream region of the gene encoding FAD-GDH and all or part of the gene encoding FAD-GDH are used for homologous recombination. All or part of the gene encoding FAD-GDH can include the region from the start codon to the intermediate region. The length of the region suitable for homologous recombination is preferably 0.5 kb or more.
[0060] The creation of transformed filamentous fungi can be confirmed by culturing the transformed filamentous fungi under conditions in which FAD-GDH enzyme activity is observed, and then checking the activity of FAD-GDH in the culture obtained after culturing.
[0061] Alternatively, confirmation that transformed filamentous fungi have been produced can be performed by extracting chromosomal DNA from the transformed filamentous fungi, using this as a template for PCR, and confirming that a PCR product capable of amplification is produced when transformation occurs.
[0062] For example, PCR is performed using a combination of a forward primer for the promoter sequence and a reverse primer for the transformation marker gene sequence to confirm that a product of the expected length is produced.
[0063] (Method for producing FAD-GDH enzyme) The FAD-GDH enzyme can be produced by culturing host cells that produce the FAD-GDH obtained as described above, expressing the FAD-GDH gene contained in the host cells, and then isolating FAD-GDH from the culture.
[0064] As a culture medium for the above-mentioned host cells, for example, one or more nitrogen sources such as yeast extract, tryptone, peptone, meat extract, corn steep liquor, or extract from soybeans or wheat bran are used, to which one or more inorganic salts such as sodium chloride, monopotassium phosphate, dipotassium phosphate, magnesium sulfate, magnesium chloride, ferric chloride, ferric sulfate, or manganese sulfate are added, and carbohydrate raw materials, vitamins, etc. are added as needed.
[0065] The initial pH of the culture medium is not limited, but can be adjusted to, for example, pH 6-9. Culturing can be carried out at a culture temperature of 10-42°C, preferably around 25°C for 4 hours to 1 week, and more preferably around 25°C for 4 hours to 5 days, by methods such as deep culture with aeration and stirring, shaking culture, or static culture.
[0066] After the culturing is complete, the FAD-GDH enzyme is collected from the culture. This can be done using conventional, known enzyme collection methods. For example, the bacterial cells can be subjected to ultrasonic disruption or grinding by conventional methods, or the enzyme can be extracted using lytic enzymes such as lysozyme or yatarase, or the enzyme can be released from the bacterial cells by shaking or standing in the presence of toluene or the like to induce lysis. Then, the solid portion of this solution is removed by filtration or centrifugation, and if necessary, nucleic acids are removed with streptomycin sulfate, protamine sulfate, or manganese sulfate, etc. After that, ammonium sulfate, alcohol, acetone, etc. are added and fractionated, and the precipitate is collected to obtain the crude FAD-GDH enzyme.
[0067] The crude FAD-GDH enzyme can be further purified using any known means. To obtain a purified enzyme preparation, for example, a gel filtration method using Sephadex, Ultrogel, or Biogel; an adsorption elution method using an ion exchanger; an electrophoresis method using a polyacrylamide gel; an adsorption elution method using hydroxyapatite; a sedimentation method such as sucrose density gradient centrifugation; an affinity chromatography method; or a fractionation method using a molecular sieve membrane or hollow fiber membrane, can be appropriately selected or combined to obtain a purified FAD-GDH enzyme preparation.
[0068] In one embodiment, glucose dehydrogenase may be immobilized on a solid phase. In one embodiment, the disclosure provides a glucose measurement kit or glucose measurement system (apparatus) comprising the substrate specificity modifier and a solid phase on which glucose dehydrogenase is immobilized. The solid phase can be, but is not limited to, beads, particles, polymers, or electrode surfaces. For example, in one embodiment, glucose dehydrogenase may be immobilized on an electrode. In one embodiment, the disclosure provides a glucose measurement system (apparatus) comprising the substrate specificity modifier and an electrode on which glucose dehydrogenase is immobilized.
[0069] (Method for immobilizing glucose dehydrogenase) Glucose dehydrogenase can be immobilized on a solid phase by any known method. Glucose dehydrogenase may be immobilized on beads, membranes, carbon particles, gold particles, platinum particles, polymers, or electrode surfaces. Immobilization methods include using crosslinking reagents, encapsulation in a polymer matrix, coating with a dialysis membrane, photocrosslinkable polymers, conductive polymers, and redox polymers. Glucose dehydrogenase may be immobilized in the polymer or adsorbed onto the electrode, or these methods may be used in combination. Typically, glucose dehydrogenase is immobilized on a carbon electrode using glutaraldehyde, and then the glutaraldehyde is blocked by treatment with a reagent having an amine group. In some embodiments, the glucose dehydrogenase substrate specificity modifier of this disclosure may be present when immobilizing glucose dehydrogenase on a solid phase surface.
[0070] In one embodiment, when glucose dehydrogenase is immobilized on an electrode or used without immobilization, known mediators are used, such as phenazine compounds such as 1-methoxy-5-methylphenadinium methylsulfate (mPMS), 5-methylphenadinium methylsulfate (PMS), and 5-ethylphenadinium methylsulfate (PES), phenothiazine compounds, ferricyanides such as potassium ferricyanide, ferrocene compounds such as ferrocene, dimethylferrocene, and ferrocenecarboxylic acid, naphthoquinone, anthraquinone, hydroquinone, pyrroloquinoline quinone, etc. Quinone compounds, cytochrome compounds, viologen compounds such as benzyl viologen and methyl viologen, indophenol compounds such as dichlorophenol indophenol, ruthenium complexes such as hexaammineruthenium chloride, osmium complexes such as osmium-2,2'-bipyridine, and phenylenediamine compounds such as p-phenylenediamine, N-isopropyl-N'-phenyl-p-phenylenediamine (IPPD), N',N-diphenyl-p-phenylenediamine (DPPD), N-(1,3-dimethylbutyl)-N'-phenyl-p-phenylenediamine, and N,N,N',N'-tetramethyl-1,4-phenylenediamine can be used. These mediators can also be used after being modified with polymers such as polyvinylimidazole, polyethyleneimine, and polyacrylic acid. Furthermore, these mediators can be immobilized on GDH using crosslinking reagents. Furthermore, these mediators can also be immobilized on electrodes by hydrophobic interactions, with reference to Japanese Patent Nos. 6484741 and 6484742. The entire contents of these patents are incorporated herein by reference. These mediators can also be immobilized on electrodes after the electrode surface has been activated by acid treatment or the like. The electrodes can be made of materials such as carbon, gold, or platinum.
[0071] The final concentration of the mediator added to the sample solution is not particularly limited and may be in the range of, for example, 1 pM to 1 M, 1 pM to 100 mM, 1 pM to 20 mM, 1 pM to 10 mM, 1 pM to 5 mM, 2 pM to 1 mM, 3 pM to 800 μM, 4 pM to 600 μM, 5 pM to 500 μM, 6 pM to 400 μM, 7 pM to 300 μM, 8 pM to 200 μM, 9 pM to 100 μM, or 10 pM to 50 μM. The order of addition of the mediator and other reagents is not restricted and may be simultaneous or sequential.
[0072] In one embodiment, the time for performing the oxidation-reduction reaction or the time for performing the electrochemical measurement can be 60 minutes or less, 30 minutes or less, 10 minutes or less, 5 minutes or less, or 1 minute or less. Alternatively, in the case of enzyme sensors or batteries that perform measurements over a long period of time, the time for performing the oxidation-reduction reaction can be 60 minutes or more, 120 minutes or more, 1 day or more, 2 days or more, 3 days or more, 1 week or more, 2 weeks or more, or 3 weeks or more.
[0073] Unless otherwise specified, the glucose dehydrogenase contained in the composition or the glucose dehydrogenase immobilized on the electrode is purified glucose dehydrogenase enzyme.
[0074] (Measurement of glucose dehydrogenase activity) This section explains the measurement of glucose dehydrogenase (GDH) activity. GDH (EC 1.1.99.10) catalyzes the oxidation of the hydroxyl group of glucose to produce glucono-δ-lactone. In this reaction, the electron acceptor accepts electrons and becomes a reduced electron acceptor. The activity of GDH can be measured using this principle of action, for example, by using the following measurement system with phenazine methosulfate (PMS) and 2,6-dichloroindophenol (DCIP) as electron acceptors. (Reaction 1) D-glucose + PMS (oxidized form) → D-glucono-δ-lactone + PMS (reduced form) (Reaction 2) PMS (reduced form) + DCIP (oxidized form) → PMS (oxidized form) + DCIP (reduced form)
[0075] Specifically, in reaction 1, PMS (reduced form) is produced as D-glucose is oxidized. Subsequently, in reaction 2, DCIP is reduced as PMS (reduced form) is oxidized. The degree of disappearance of this "DCIP (oxidized form)" is detected as a change in absorbance at a wavelength of 600 nm, and the enzyme activity can be determined based on this change.
[0076] GDH activity can be measured by the following procedure: Mix 2.05 mL of 100 mM phosphate buffer (pH 7.0), 0.6 mL of 1 M D-glucose solution, and 0.15 mL of 2 mM DCIP solution, and incubate at 37°C for 5 minutes. Then, add 0.1 mL of 15 mM PMS solution and 0.1 mL of enzyme sample solution to start the reaction. Measure the absorbance at the start of the reaction and over time, and determine the decrease in absorbance at 600 nm per minute (ΔA600) as the enzymatic reaction progresses. Calculate the GDH activity according to the following formula. In this case, GDH activity is defined as the amount of enzyme that reduces 1 μmol of DCIP per minute in the presence of 200 mM D-glucose at 37°C, with 1 U being defined.
[0077]
number
[0078] In the formula, 3.0 represents the volume of the reaction reagent + enzyme reagent (mL), and 16.3 represents the millimolar molecular extinction coefficient (cm²) under these activity measurement conditions. 2 ( / μmol), 0.1 is the volume of the enzyme solution (mL), 1.0 is the optical path length of the cell (cm), ΔA600 blank is the decrease in absorbance per minute at 600 nm when 100 mM phosphate buffer (pH 7.0) is added instead of the enzyme sample solution to initiate the reaction, and df represents the dilution factor.
[0079] The glucose measurement kit of this disclosure contains a sufficient amount of substrate specificity modifier for at least one assay. Typically, the glucose measurement kit of this disclosure includes, in addition to the substrate specificity modifier, glucose dehydrogenase, buffers required for the assay, glucose substrate standard solutions for calibration curve preparation, and guidelines. The substrate standard solution may be a glucose standard solution. Note that when evaluating the reactivity of glucose dehydrogenase to maltose, a maltose substrate standard solution of known concentration may also be used.
[0080] In one embodiment, the glucose measurement kit of the Disclosure comprises a substrate specificity modifier and glucose dehydrogenase as the same reagent. In another embodiment, the glucose measurement kit of the Disclosure comprises a substrate specificity modifier and glucose dehydrogenase as separate reagents. In yet another embodiment, the glucose dehydrogenase may be immobilized on an electrode, and the glucose measurement kit of the Disclosure used with such an electrode comprises the substrate specificity modifier as a single reagent. However, the term "single reagent" as used herein does not mean that the reagent does not contain any substances other than the substrate specificity modifier. The substrate specificity modifier may be in solution or dry state, for example, as a powder.
[0081] One example of a colorimetric method is the measurement of glucose concentration. For colorimetric measurements, glucose concentration can be measured as follows: The reaction layer contains a liquid or solid composition containing glucose dehydrogenase (GDH) and one or more substances selected from the group consisting of N-(2-acetamide)imide diacetic acid (ADA), bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane (Bis-Tris), sodium carbonate, and imidazole as reaction accelerators. A pH buffer and a colorimetric reagent (color-changing reagent) are added as needed. A sample containing glucose is added and allowed to react for a certain period of time. During this time, the absorbance corresponding to the maximum absorption wavelength of the dye produced by polymerization or the reduced dye by directly receiving electrons from GDH is monitored. In the rate method, the glucose concentration in the sample can be calculated from the rate of change of absorbance per unit time, or in the endpoint method, from the change in absorbance until all the glucose in the sample is oxidized, based on a calibration curve prepared in advance using a standard concentration glucose solution.
[0082] In this method, for example, 2,6-dichloroindophenol (DCIP) can be added as an electron acceptor, and glucose can be quantified by monitoring the decrease in absorbance at 600 nm. Alternatively, by adding nitrotetrazolium blue (NTB) as a colorimetric reagent and measuring the absorbance at 570 nm, the amount of diformazan produced can be determined, and the glucose concentration can be calculated. Needless to say, the colorimetric reagents used are not limited to these.
[0083] (Enzyme sensor) In one embodiment, glucose can be detected or measured by an enzyme sensor. The enzyme sensor may include an electrode on which glucose dehydrogenase is immobilized. The above-mentioned mediator may also be adsorbed on the electrode. Examples of electrodes for the enzyme sensor include carbon electrodes, gold electrodes, and platinum electrodes, on which glucose dehydrogenase can be coated or immobilized. Furthermore, the conductive material may include metal nanoparticles containing at least one element from Co, Pd, Rh, Ir, Ru, Os, Re, Ni, Cr, Fe, Mo, Ti, Al, Cu, V, Nb, Zr, Sn, In, Ga, Mg, Pb, Au, Pt, and Ag, and these may be alloys or plated materials. As carbon, carbon nanotubes, carbon black, graphite, fullerenes, and their derivatives are also included. In one embodiment, the enzyme sensor may be a glucose sensor. That is, in one embodiment, the present disclosure provides a method for detecting or measuring glucose using the above-mentioned substrate specificity modifier and glucose sensor. This glucose sensor can be used for continuous glucose monitoring and continuous blood glucose measurement.
[0084] The compositions or reagents containing the substrate specificity modifiers of this disclosure can be used in various electrochemical measurements using potentiostats, galvanostats, etc., together with electrodes immobilized with glucose dehydrogenase or enzyme sensors. Examples of electrochemical measurement methods include various techniques such as amperometry (e.g., chronoamperometry, potential-step chronoamperometry), voltammetry (e.g., cyclic voltammetry, differential pulse voltammetry, potentiometry, coulometry), etc. For example, in glucose measurement, the glucose concentration in the sample can be calculated by measuring the current when glucose is reduced using the amperometry method. The applied voltage depends on the conditions and instrument settings, but can be, for example, -1000mV to +1000mV (vs. Ag / AgCl).
[0085] A printed electrode can also be used as the electrode. This makes it possible to reduce the amount of solution required for measurement. The electrode can be formed on an insulating substrate. Specifically, the electrode can be formed on the substrate by photolithography techniques, or printing techniques such as screen printing, gravure printing, and flexographic printing. Examples of the material for the insulating substrate include silicon, glass, ceramic, polyvinyl chloride, polyethylene, polypropylene, and polyester, and materials with high resistance to various solvents and chemicals can be used. In addition, carbon cloth, carbon paper, or bucky paper can also be used as the electrode substrate. The area of the working electrode can be set according to the desired response current. For example, in some embodiments, the area of the working electrode is 1 mm 2 or more, 1.5 mm 2 or more, 2 mm 2 or more, 2.5 mm 2 or more, 3 mm 2 or more, 4 mm 2 or more, 5 mm 2 or more, 6 mm 2 or more, 7 mm 2 or more, 8 mm 2 or more, 9 mm 2 or more, 10 mm 2 or more, 12 mm 2 or more, 15 mm 2 or more, 20 mm 2 or more, 30 mm 2 or more, 40 mm 2 or more, 50 mm 2 or more, 1 cm 2 or more, 2 cm 2 or more, 3 cm 2 or more, 4 cm 2 or more, 5 cm 2 or more, for example 10 cm 2 or more. In some embodiments, the area of the working electrode can be 10 cm 2 or less, 5 cm 2 or less, for example 1 cm 2 or less. The counter electrode may be the same. In addition, carbon nanotubes, graphene, Ketjen black, etc. can be immobilized on the working electrode to increase the apparent surface area. In this case, the apparent area can be increased by 10 times or more, 50 times or more, 100 times or more, or 1000 times or more.
[0086] In one embodiment, the present disclosure provides a method for screening glucose dehydrogenase substrate specificity modifiers. This method is i) Steps to prepare glucose dehydrogenase, ii) A step of determining the ratio (Mal / Glu) of the reactivity of the glucose dehydrogenase to maltose (Mal) and to glucose (Glu), iii) A step of contacting the glucose dehydrogenase described in i) with a candidate substance, and then determining the ratio (Mal / Glu) of the reactivity of the glucose dehydrogenase to maltose (Mal) to glucose (Glu) in the presence of the candidate substance. iv) A step of comparing the ratio (Mal / Glu) in ii) above with the ratio (Mal / Glu) in the presence of the candidate substance in iii), and v) If the ratio (Mal / Glu) in the presence of the candidate substance in iii) is modified compared to the ratio (Mal / Glu) in ii), the procedure includes a step of using the candidate substance as a glucose dehydrogenase substrate specificity modifier. The candidate substance may be a small molecule compound that is an analog of glucose.
[0087] In one embodiment, the present disclosure provides a method for determining the effective concentration of a glucose dehydrogenase substrate specificity modifier. This method is i) A step of preparing glucose dehydrogenase and glucose dehydrogenase substrate specificity modifiers at first, second, ..., nth concentrations (where n is a natural number), ii) A step of determining the ratio (Mal / Glu) of the reactivity of glucose dehydrogenase to maltose (Mal) to glucose (Glu) in the presence of the glucose dehydrogenase substrate specificity modifier at the first, second, ..., and n concentrations, iii) A step to confirm the effective concentration of the glucose dehydrogenase substrate specificity modifier by comparing the ratio (Mal / Glu) at each concentration. This includes the following. For example, in one embodiment, if the ratio Mal / Glu at a specific concentration n is substantially the same as the ratio Mal / Glu when no glucose dehydrogenase substrate specificity modifier is added, the lower limit of the effective concentration of the glucose dehydrogenase substrate specificity modifier can be set to the specific concentration n or higher. In one embodiment, if the ratio Mal / Glu at a specific concentration n is substantially the same as the ratio Mal / Glu when the glucose dehydrogenase substrate specificity modifier is added at a concentration of n-1, the upper limit of the effective concentration of the glucose dehydrogenase substrate specificity modifier can be set to the specific concentration n or lower. However, concentration n is set to be higher than concentration n-1.
[0088] In one embodiment, the disclosure provides a method for producing a glucose measurement reagent or glucose measurement composition, comprising incorporating a glucose dehydrogenase substrate specificity modifier identified by the screening method into the glucose measurement reagent or glucose measurement composition. In another embodiment, the disclosure provides a glucose measurement reagent comprising a glucose dehydrogenase substrate specificity modifier identified by the screening method and glucose dehydrogenase.
[0089] The ratio of the reactivity of glucose dehydrogenase to maltose (Mal) to glucose (Glu) (Mal / Glu) can be determined by the following procedure: N-isopropyl-N'-phenyl-p-phenylenediamine (IPPD) is adsorbed and immobilized onto a carbon printed electrode, and glucose dehydrogenase, such as glucose dehydrogenase from the genus Mucor or glucose dehydrogenase from the genus Aspergillus, is crosslinked and immobilized with glutaraldehyde. Chronoamperometry is performed using a three-electrode system consisting of a working electrode, a counter electrode, and a reference electrode, with a potential of +250 mV (Ag / AgCl) applied. After the current value has stabilized sufficiently, maltose is added in phosphate-buffered saline (PBS) to a final concentration of 1 mM (for example, added 100 seconds after the start of measurement). Next, after the current value has stabilized sufficiently again after the addition of maltose, glucose is added in phosphate-buffered saline (PBS) to a final concentration of 1 mM (for example, added 100 seconds after the addition of maltose). The substrate specificity of glucose dehydrogenase can be evaluated by measuring its reactivity to maltose, with its reactivity to glucose set as 100%. In this specification, the ratio of reactivity to maltose (Mal) to reactivity to glucose (Glu) may be denoted as Mal / Glu. When reactivity is evaluated by response current, the ratio of reactivity can be referred to as the ratio of response currents.
[0090] For example, if the Mal / Glu ratio of a certain glucose dehydrogenase is 0.50% in the absence of a glucose dehydrogenase substrate specificity modifier, then if the Mal / Glu ratio of the same glucose dehydrogenase is less than 0.50% under the same measurement conditions, but in the presence of the glucose dehydrogenase substrate specificity modifier, then it can be said that the reactivity to maltose has been reduced and the substrate specificity of the glucose dehydrogenase has been modified. Such a glucose dehydrogenase substrate specificity modifier can reduce the influence of maltose in glucose measurement. Alternatively, the relative value of Mal / Glu for a certain glucose dehydrogenase in the absence of a glucose dehydrogenase substrate specificity modifier may be defined as 100%. In this case, if the Mal / Glu ratio of the glucose dehydrogenase is less than 100% under the same measurement conditions, but in the presence of the glucose dehydrogenase substrate specificity modifier, then it can be said that the reactivity to maltose has been reduced and the substrate specificity of the glucose dehydrogenase has been modified. Furthermore, if the Mal / Glu ratio of the glucose dehydrogenase is 100% or higher in the presence of a glucose dehydrogenase substrate specificity modifier, it can be said that the reactivity to maltose has increased, and the substrate specificity of the glucose dehydrogenase has been modified.
[0091] In one embodiment, if the Mal / Glu ratio of a certain glucose dehydrogenase is taken as 100% in the absence of the glucose dehydrogenase substrate specificity modifier, then the Mal / Glu ratio of the glucose dehydrogenase in the presence of the glucose dehydrogenase substrate specificity modifier of this disclosure is 99% or less, 98% or less, 97% or less, 96% or less, 95% or less, 94% or less, 93% or less, 92% or less, 91% or less, 90% or less, 89% or less, 88% or less, 87% or less, 86% or less, 85% or less, 84% or less, 83% or less, 82% or less, 81% or less, and 80% or less. , 79% or less, 78% or less, 77% or less, 76% or less, 75% or less, 74% or less, 73% or less, 72% or less, 71% or less, 70% or less, 69% or less, 68% or less, 67% or less, 66% or less, 65% or less, 64% or less, 63% or less, 62% or less, 61% or less, 60% or less, 59% or less Lower, 58% or less, 57% or less, 56% or less, 55% or less, 54% or less, 53% or less, 52% or less, 51% or less, 50% or less, 49% or less, 48% or less, 47% or less, 46% or less, 45% or less, 44% or less, 43% or less, 42% or less, 41% or less, 40% or less, 39% or less, 38% Below, 37% or less, 36% or less, 35% or less, 34% or less, 33% or less, 32% or less, 31% or less, 30% or less, 29% or less, 28% or less, 27% or less, 26% or less, 25% or less, 24% or less, 23% or less, 22% or less, 21% or less, 20% or less, 19% or less, 18% or less, 17 % or less, 16% or less, 15% or less, 14% or less, 13% or less, 12% or less, 11% or less, 10% or less, 9% or less, 8% or less, 7% or less, 6% or less, 5% or less, 4% or less, 3% or less, 2% or less, e.g. 1% or less, e.g. substantially 0%, e.g. 0%, e.g. 99%~0%, 99%~1 %, 98%~2%, 97%~3%, 96%~4%, 95%~5%, 94%~6%, 93%~7%, 92%~8%, 91%~9%, 90%~10%, 89%~11%, 88%~12%, 87%~13%, 86%~14%, 85%~15%, 84%~16%, 83%~17%, 82% ~18%, 81%~19%, 80%~20%, 79%~21%, 78%~22%, 77%~23%, 76%~24%, 75%~25%, 74%~26%, 73%~27%, 72%~28%, 71%~29%, 70%~30%, 69%~31%, 68%~32%, 67%~33%,It could be 66%~34%, 65%~35%, 64%~36%, 63%~37%, 62%~38%, 61%~39%, 60%~40%, 59%~41%, 58%~42%, 57%~43%, 56%~44%, 55%~45%, 54%~46%, 53%~47%, 52%~48%, 51%~49%, or even 50%.
[0092] In one embodiment, if the Mal / Glu ratio of a certain glucose dehydrogenase is taken as 100% in the absence of the glucose dehydrogenase substrate specificity modifier, the Mal / Glu ratio of the glucose dehydrogenase in the presence of the glucose dehydrogenase substrate specificity modifier of the present disclosure may be 110% or more, 120% or more, 130% or more, 140% or more, 150% or more, 160% or more, 170% or more, 180% or more, 190% or more, 200% or more, 220% or more, 240% or more, 260% or more, 280% or more, 300% or more, for example, 110%~300%, 120%~280%, 130%~260%, 140%~240%, 150%~220%, 160%~200%, for example, 170%~190%. Unless otherwise specified, numerical ranges in this disclosure include upper and lower limits (for example, numerical range a to b means a or greater and b or less). This disclosure also includes all combinations of upper and lower limits exemplified for numerical ranges.
[0093] While we do not wish to be bound by any particular theory, the glucose dehydrogenase substrate specificity modifiers of this disclosure are thought to be able to modify the substrate specificity of GDH through the following mechanism of action. That is, glucose dehydrogenase is known to recognize and act on glucose through its substrate pocket, but it is thought that compounds with a chemical structure similar to glucose (glucose analogs) enter the substrate pocket first, preventing other contaminating sugars, such as maltose, from entering the substrate pocket. Although glucose is a C6 compound and glycerol is a C3 compound, it can be said that glycerol has a structure that matches a part of glucose, and since glycerol also showed the effect of modifying the substrate specificity of glucose dehydrogenase, it is thought that glycerol enters the substrate pocket or interacts with the substrate pocket.
[0094] This disclosure makes it possible to modify the substrate specificity of glucose dehydrogenase. Furthermore, this disclosure can be combined with other methods for modifying the substrate specificity of glucose dehydrogenase. For example, a glucose dehydrogenase with high substrate specificity can be searched for, and the newly discovered glucose dehydrogenase can be used in combination with the GDH substrate specificity modifier of this disclosure. Alternatively, for example, the substrate specificity of GDH can be modified, and the modified GDH variant can be used in combination with the GDH substrate specificity modifier of this disclosure.
[0095] In one embodiment, the glucose dehydrogenase substrate specificity modifier used in the glucose measurement method of this disclosure may include one or more compounds selected from the group consisting of L-growth, D-iditol, L-iditol, D-glucar, sorbitol, ribitol, and trehalose, as well as D-mannitol, xylitol, and glycerol. The glucose dehydrogenase may be a Mucor-derived FAD-GDH, for example, Mucor prainii-derived GDH (MpGDH), and the FAD-GDH may or may not be immobilized on the electrode.
[0096] In one embodiment, the glucose dehydrogenase substrate specificity modifier used in the glucose measurement method of this disclosure may include one or more compounds selected from the group consisting of L-growth, D-iditol, D-glucar, sorbitol, ribitol, and trehalose, as well as D-mannitol, xylitol, and glycerol. The glucose dehydrogenase may be a Mucor-derived FAD-GDH, for example, Mucor RD056860 GDH (MrdGDH), and the FAD-GDH may or may not be immobilized on the electrode.
[0097] In one embodiment, the glucose dehydrogenase substrate specificity modifier used in the glucose measurement method of this disclosure may include one or more compounds selected from the group consisting of L-growth, D-iditol, D-glucar, ribitol, and trehalose, as well as D-mannitol, xylitol, and glycerol. The glucose dehydrogenase may be FAD-GDH derived from the genus Aspergillus, for example, FAD-GDH derived from Aspergillus oryzae or Aspergillus tereus, or GLD1, and the FAD-GDH may or may not be immobilized on the electrode.
[0098] By using the substrate specificity modifier of this disclosure, the substrate specificity of glucose dehydrogenase can be modified. This reduces the influence of maltose when measuring the glucose concentration of a sample using glucose dehydrogenase, enabling more accurate glucose concentration measurement. This may be useful for managing blood glucose levels in diabetic patients.
[0099] (Electrodes of this disclosure) In one embodiment, the Disclosure provides an electrode comprising a glucose dehydrogenase substrate specificity modifier. In one embodiment, the electrode may be an anode electrode. In one embodiment, the anode electrode of the Disclosure comprises glucose dehydrogenase. In one embodiment, the glucose dehydrogenase may be immobilized on an electrode of a battery. In one embodiment, the anode electrode of the Disclosure can be combined with a cathode electrode and a resistor to provide a battery. In one embodiment, the Disclosure provides a method for generating power using the battery described above. In another embodiment, a battery comprising the glucose dehydrogenase substrate specificity modifier of the Disclosure is provided.
[0100] (Fuel cell of this disclosure) In one embodiment, the Disclosure provides an anode or cathode for a fuel cell and a fuel cell equipped with said anode or cathode. This fuel cell includes the glucose dehydrogenase substrate specificity modifier of the Disclosure. In one embodiment, the Disclosure provides a method for generating electricity using a battery containing the glucose dehydrogenase substrate specificity modifier, and a method for generating electricity in the presence of the glucose dehydrogenase substrate specificity modifier, using a substrate corresponding to the glucose dehydrogenase, such as glucose, as fuel, with glucose dehydrogenase immobilized on the anode electrode.
[0101] In one embodiment, the fuel cell of the present disclosure comprises the glucose dehydrogenase substrate specificity modifier, an anode or cathode, a fuel tank, a cathode, an anode having glucose dehydrogenase, and an electrolyte. An artificial electron mediator may be adsorbed on the anode or cathode. Examples of artificial electron mediators include, but are not limited to, the known mediators described above, and phenylenediamine compounds described in Japanese Patent Nos. 6484741 and 6484742. The fuel cell of the present disclosure may also be provided with wiring to place a load resistor between the anode and the cathode as needed. In one embodiment, the load resistor is part of the fuel cell of the present disclosure. In one embodiment, the load resistor is not part of the fuel cell of the present disclosure, and the fuel cell of the present disclosure is configured to be connected to an appropriate load resistor. In the fuel cell of the present disclosure, oxidoreductase (GDH) constitutes part of the anode. For example, the oxidoreductase may be in close proximity to or in contact with the anode, immobilized, or adsorbed. The fuel tank contains a compound that serves as a substrate for the oxidoreductase immobilized on the electrode. For example, if glucose dehydrogenase is immobilized on the electrode, the fuel may be glucose. In one embodiment, the fuel cell of this disclosure may have an ion exchange membrane that separates the anode and the cathode. The ion exchange membrane may have pores of 1 nm to 20 nm. The anode may be a general electrode such as a carbon electrode. For example, electrodes made of conductive carbonaceous materials such as carbon black, graphite, and activated carbon, or electrodes made of metals such as gold and platinum can be used. Specifically, examples include carbon paper, carbon cloth, glassy carbon, carbon nanotubes, and HOPG (highly oriented pyrolysis graphite). As the corresponding cathode, for example, an electrode in which an electrode catalyst commonly used in fuel cells, such as platinum or a platinum alloy, is supported on a conductor made of carbonaceous material such as carbon black, graphite, or activated carbon, or on a conductor made of the electrode catalyst itself, such as platinum or a platinum alloy, can be used as the cathode electrode, and an oxidizing agent (cathode-side substrate, oxygen, etc.) can be supplied to the electrode catalyst.
[0102] In another embodiment, a substrate-reducing enzyme electrode may be used as the cathode paired with the anode consisting of the substrate-oxidizing enzyme electrode described above. Examples of oxidoreductases that reduce the oxidizing agent include known enzymes such as laccase and bilirubin oxidase. When using an oxidoreductase as a catalyst for reducing the oxidizing agent, a known electron transfer mediator may be used as needed. Examples of oxidizing agents include oxygen.
[0103] In one embodiment, an oxygen-selective film (e.g., a dimethylpolysiloxane film) can be placed around the cathode electrode to avoid the influence of impurities (such as ascorbic acid or uric acid) that interfere with the electrode reaction at the cathode.
[0104] The power generation method of this disclosure includes the step of supplying a compound that serves as a substrate for the oxidoreductase, which is a fuel, to an anode having an oxidoreductase. When the fuel is supplied to the anode having the oxidoreductase, the substrate is oxidized, and the oxidoreductase simultaneously transfers the generated electrons to an electron transfer mediator, such as a phenylenediamine-based compound, which mediates electron transfer between the oxidoreductase and the electrode, and the electrons are then transferred to a conductive substrate (anode electrode) by the electron transfer mediator. An electric current is generated when electrons reach the cathode electrode from the anode electrode through wiring (external circuit).
[0105] Protons (H) generated in the above process + The protons move through the electrolyte solution to the cathode electrode. At the cathode electrode, the protons that have moved from the anode through the electrolyte solution, the electrons that have moved from the anode side via an external circuit, and an oxidizing agent such as oxygen or hydrogen peroxide (cathode substrate) react to produce water. This can be used to generate electricity.
[0106] In one embodiment, endogenous glucose can be used as fuel for the anode. In this case, if it reacts with endogenous maltose, a current greater than expected may flow, and in order to control the current, it is considered that the glucose dehydrogenase needs to exhibit substrate specificity that acts only on glucose. The substrate specificity modifier of this disclosure can also be used for such applications.
[0107] In some descriptions of this disclosure, the ratio of glucose dehydrogenase's reactivity to maltose to glucose (Mal / Glu) can be "modified." Here, "modification" can include "reduction." For example, if it is desired to reduce the influence of maltose when measuring glucose concentration, it is preferable to reduce the ratio (Mal / Glu). In these embodiments, "modification" in each description shall be read as "reduction." According to this disclosure, the substrate specificity of GDH can be changed according to the application using the above-mentioned substrate specificity modifier without genetically modifying glucose dehydrogenase.
[0108] In one embodiment, the Disclosure provides a method for modifying the substrate specificity of glucose dehydrogenase by using a glucose analog and low molecular weight compound glucose dehydrogenase substrate specificity modifier. In another embodiment, the Disclosure provides the use of a glucose analog and low molecular weight compound glucose dehydrogenase substrate specificity modifier for modifying the substrate specificity of glucose dehydrogenase. In yet another embodiment, the Disclosure provides a glucose analog and low molecular weight compound glucose dehydrogenase substrate specificity modifier for use in modifying the substrate specificity of glucose dehydrogenase. In one embodiment, the method of the Disclosure does not involve medical practice. [Examples]
[0109] The present invention is further illustrated by the following examples. However, the technical scope of the present invention is not limited in any way by these examples.
[0110] [Example 1] Introduction of a Mucor-derived GDH gene into a host and confirmation of GDH activity The amino acid sequence of Mucor-derived GDH (MpGDH) described in Japanese Patent No. 4648993 is shown in Sequence ID No. 1, and the nucleotide sequence is shown in Sequence ID No. 2. Based on the disclosure in Japanese Patent Publication No. 2013-176363, a nucleotide sequence encoding MrdGDH having the amino acid sequence of Sequence ID No. 3 was totally synthesized (Sequence ID No. 4). A DNA construct was prepared by inserting the target gene, either the MpGDH gene or the MrdGDH gene, into the multi-cloning site of plasmid pUC19 using a conventional method. Specifically, pUC19 used was the pUC19 linearized vector included with the In-Fusion HD Cloning Kit (Clontech). At the In-Fusion Cloning Site located in the multi-cloning site of pUC19, the MpGDH gene or the MrdGDH gene was ligated using the In-Fusion HD Cloning Kit according to the protocol provided with the kit to obtain construct plasmids (pUC19-MpGDH, pUC19-MrdGDH).
[0111] These genes were expressed in the mold Aspergillus sojae, and their GDH activity was evaluated.
[0112] Specifically, with the aim of obtaining MpGDH or MrdGDH, a cassette consisting of the 5' arm region, pyrG gene, TEF1 promoter gene, flavin-bound GDH gene, and 3' arm region was constructed using Double-joint PCR (Fungal Genetics and Biology, 2004, Vol. 41, pp. 973-981) with the GDH gene. This cassette was then used to transform a pyrG knockout strain (a knockout strain with a 48 bp upstream, 896 bp coding region, and 240 bp downstream deletion of the pyrG gene) derived from Aspergillus soybean NBRC4239 strain using the following procedure. Note that the pyrG gene is a uracil nutrient requirement marker. Conidia from a pyrG knockout strain of Aspergillus soybean NBRC4239 were inoculated into 100 ml of polypeptone dextrin liquid medium containing 20 mM uridine in a 500 ml Erlenmeyer flask. After incubation with shaking at 30°C for approximately 20 hours, the cells were collected. Protoplasts were prepared from the collected cells. The obtained protoplasts and 20 μg of target gene insertion DNA construct were transformed by the protoplast PEG method. Subsequently, the cells were incubated in Czapek-Dox minimal medium (DIFCO; pH 6) containing 0.5% (w / v) agar and 1.2 M sorbitol at 30°C for more than 5 days to obtain transformed Aspergillus soybean with colony-forming ability.
[0113] The resulting transformed Aspergillus soybeans could be selected as the strain containing the desired gene because the pyrG gene, which complements the uridine requirement, was introduced, allowing it to grow in uridine-free medium. From the obtained strains, the desired transformants were selected by PCR.
[0114] GDH production was carried out using transformed Aspergillus soybeans transformed with the MpGDH or MrdGDH gene.
[0115] Conidia from each strain were inoculated into 40 ml of DPY liquid medium (1% (w / v) polypeptone, 2% (w / v) dextrin, 0.5% (w / v) yeast extract, 0.5% (w / v) KH2PO4, 0.05% (w / v) MgSO4·7H2O; pH unadjusted) in a 200 ml Erlenmeyer flask, and cultured at 30°C for 4 days with shaking at 160 rpm. Subsequently, the bacterial cells were filtered from the culture, and the resulting supernatant fraction was concentrated and desalted to 10 ml using Amicon Ultra-15, 30K NMWL (Millipore), and replaced with 20 mM potassium phosphate buffer (pH 6.5) containing 150 mM NaCl. Next, the enzymes were applied to 200pg of HiLoad 26 / 60 Superdex (GE Healthcare) equilibrated with 20mM potassium phosphate buffer (pH 6.5) containing 150mM NaCl. Elution was performed with the same buffer, and the fraction showing GDH activity was collected to obtain a purified MpGDH standard. A purified MrdGDH standard was obtained in the same manner. Note that these enzymes are in a state where they are bound to FAD via their FAD binding site (holoenzymes).
[0116] [Example 2] Effect of substrate specificity modifier when using immobilized enzymes 10 μL of purified 12 mg / ml MpGDH standard, 10 μL of each 15 mM glucose analog, and 10 μL of 20 mM potassium phosphate buffer were mixed and allowed to stand for at least 2 hours. N-isopropyl-N'-phenyl-p-phenylenediamine (IPPD) was adsorbed and immobilized onto a screen-printed electrode (DropSens, product number DRP-C110), and 12 μg of each MpGDH was spread onto it and dried at room temperature. Finally, the electrode was immersed in 25% glutaraldehyde vapor, and the resulting electrode was washed with pure water to create an IPPD-MpGDH immobilized electrode. Next, using a dedicated connector (DRP-CAC), the electrode was connected to an ALS electrochemical analyzer 814D, and the IPPD-MpGDH immobilized electrode, Ag / AgCl reference electrode, and platinum counter electrode were immersed in PBS to perform chronoamperometry. The applied voltage was +250mV (Ag / AgCl). After the current value had stabilized sufficiently (approximately 100 seconds after the start of measurement), maltose was added to PBS to a final concentration of 1 mM. Next, after the current value had stabilized sufficiently again (approximately 100 seconds after the addition of maltose), glucose solution was added to a final concentration of 1 mM. The difference in response current before and after maltose addition was recorded as the maltose response current value, and the difference in response current before and after glucose addition was recorded as the glucose response current value. The maltose / glucose (%) value was calculated by dividing the maltose response current value by the glucose response current value. The results are shown in Table 1. Sorbitol, ribitol, L-glucose, and D-iditol modified the substrate specificity. Furthermore, when the maltose / glucose of MpGDH without the addition of a substrate specificity modifier was set to 100%, the value when D-glucar was added became 69%, thus modifying the substrate specificity.
[0117] [Table 1]
[0118] Similarly, the effects of substrate specificity modifiers were investigated using glucose dehydrogenase (FAD-dependent) (BBI, Product Code: GLD1, hereinafter referred to as GLD1). The results are shown in Table 2. L-growth, D-iditol, L-iditol, trehalose, and D-glucar modified substrate specificity.
[0119] [Table 2]
[0120] Similarly, the effects of substrate specificity modifiers were investigated using MrdGDH. The results are shown in Table 3. Sorbitol, D-iditol, trehalose, and D-glucar modified substrate specificity.
[0121] [Table 3]
[0122] [Example 3] Effect of substrate specificity modifier when using an unimmobilized enzyme 10 μL of purified 12 mg / ml MpGDH standard, 10 μL of each 15 mM glucose analog, and 10 μL of 20 mM potassium phosphate buffer were mixed and allowed to stand for at least 2 hours. 80 μL of PBS, 5 μL of each MpGDH solution, and 10 μL of 2 mg / ml mPMS solution were spread and mixed onto a screen-printed electrodes (DropSens, product number DRP-C110). Chronoamperometry was performed with an applied voltage of +100 mV (Ag / Ag+). After the current value had stabilized sufficiently (approximately 100 seconds after the start of measurement), maltose solution was added to a final concentration of 5 mM and mixed by pipetting. The measurement was stopped when the current value had stabilized sufficiently, and the difference before and after maltose addition was taken as the maltose response current value. Note that when an equal volume of pure water was added instead of maltose solution, no increase in response current was observed. The printed electrodes used were thoroughly washed with ultrapure water and dried, and chronoamperometry measurements were performed in the same manner as above. Glucose solution was added instead of maltose solution, and the response current value for glucose was measured. The maltose / glucose ratio (%) was calculated by dividing the maltose response current value by the glucose response current value. When the maltose / glucose ratio of MpGDH was set to 100%, the ratio became 67% when sorbitol was added, 58% when ribitol was added, 56% when L-growth was added, 84% when D-iditol was added, 68% when L-iditol was added, and 72% when trehalose was added, thus modifying the substrate specificity. It was found that L-iditol acts as a substrate specificity modifier when the enzyme is not immobilized.
[0123] Similarly, the effects of substrate specificity modifiers were investigated using GLD1. The results are shown in Table 4. Ribitol, L-growth, L-iditol, trehalose, and D-glucar modified the substrate specificity.
[0124] [Table 4]
[0125] Similarly, the effects of substrate specificity modifiers were investigated using MrdGDH. The results are shown in Table 5. Sorbitol, ribitol, L-growth, D-iditol, and trehalose modified the substrate specificity.
[0126] [Table 5]
[0127] [Example 4] Effect of substrate specificity modifier when using carbon cloth electrodes A 1.4 wt% solution of multi-walled carbon nanotubes (MWCNT solution) with 80 μl of N'N-diphenyl-p-phenylenediamine (DPPD) adsorbed and immobilized was applied in multiple stages to a 5 mm square carbon cloth (manufactured by Toyo Technica Co., Ltd.). After thorough drying, the cloth was washed with ultrapure water. Subsequently, 20 μl of a solution prepared by mixing 40 mg / ml wild-type MpGDH with 20 μl of various glucose analogs at 100 mM dissolved in ultrapure water was applied to the MWCNT / DPPD-immobilized electrode. After drying at room temperature, the MpGDH was cross-linked and immobilized by immersion in 25% glutaraldehyde vapor for 20 minutes. Afterward, the electrode was washed with ultrapure water in the same manner as above to obtain the MWCNT / DPPD / MpGDH-immobilized electrode. Next, this was connected to an ALS electrochemical analyzer 814D, and a MWCNT / DPPD / MpGDH immobilized electrode, an Ag / AgCl reference electrode, and a platinum counter electrode were immersed in PBS, and chronoamperometry measurements were performed. The applied voltage was +250 mV (Ag / AgCl). At this time, after the current value had stabilized sufficiently (approximately 100 seconds after the start of measurement), maltose was added to the PBS to a final concentration of 1 mM. Next, after the current value had stabilized sufficiently again after the addition of the maltose solution (approximately 50 seconds after the addition of maltose), a glucose solution was added to a final concentration of 1 mM. The difference in response current before and after the addition of maltose was recorded as the maltose response current value, and the difference in response current before and after the addition of glucose was recorded as the glucose response current value. The value obtained by dividing the maltose response current value by the glucose response current value was calculated as maltose / glucose (%). These results are shown in the table below. L-growth, L-iditol, D-mannitol, glycerol, and xylitol modified the substrate specificity of GDH. Furthermore, it was shown that various glucose analogs can modify the substrate specificity of GDH regardless of the electrode shape.
[0128] [Table 6]
[0129] [Example 5] Effects of combining substrate specificity modifiers in carbon cloth electrodes Similar to Example 4, MWCNT / DPPD / MpGDH immobilized electrodes were prepared. However, the only difference was that 20 μl of a solution prepared by mixing 20 μl of 40 mg / ml wild-type MpGDH with 10 μl each of 100 mM glycerol and 100 mM L-iditol dissolved in ultrapure water was applied to the MWCNT / DPPD immobilized electrode. Subsequently, chronoamperometry was performed using the method described in Example 4, and the maltose / glucose (%) ratio was calculated. As a result, when the maltose / glucose response current ratio of MpGDH without substrate specificity modifiers was set to 100%, the ratio became 8% when both glycerol and L-iditol were added, indicating a modification of substrate specificity. Therefore, it was found that when 25 mM L-iditol and glycerol were added together, the substrate specificity modification effect was greater compared to when 50 mM of each substance was used alone, and that the substrate specificity modification effect can be synergistically modified by combining different glucose analogs.
[0130] [Example 6] Construction of a fuel cell The carbon cloth electrode prepared in Example 4, using a solution containing purified GDH and D-mannitol, was used as the anode electrode. However, IPPD was used as the mediator instead of DPPD. The cathode electrode was prepared by adsorbing 10 mg / ml of bilirubin oxidase (BOD, Sigma-A) onto carbon cloth adsorbed with a multi-wall carbon nanotube solution (1.4 wt%, MWCNT solution). A variable resistor was connected between the anode and cathode electrodes, and an ALS electrochemical analyzer 814D was further connected. The fuel tank used an electrolyte solution containing PBS (pH 7.4) and 200 mM D-glucose, and the anode and cathode electrodes were immersed in it. Measurements were taken at room temperature using the open-circuit potential technique of a potentiostat. As a result, 0.125 mA / cm was obtained with a 10 kΩ connection. 2 The current value was obtained.
[0131] While we do not wish to be bound by any particular theory, the fuel cell of this disclosure can be considered as follows. Specifically, in Example 4, by using an electrode immobilized with GDH in the presence of various glucose analogs, it was possible to react with glucose with high substrate specificity. Therefore, for example, a fuel cell using the anode electrode of this disclosure is expected to be able to maintain a constant current even when using biological components in which maltose and glucose coexist as fuel, such as when maltose concentration temporarily increases after ingesting food or intravenous fluids. It is possible to modify the enzyme through genetic engineering to alter substrate specificity, but this is time-consuming and complicated. According to this disclosure, the substrate specificity of GDH can be modified according to the application. This is advantageous in various applications. [Industrial applicability]
[0132] This disclosure makes it possible to modify the substrate specificity of glucose dehydrogenase. This reduces the influence of maltose when measuring the glucose concentration of a sample using glucose dehydrogenase, enabling more accurate glucose concentration measurement. This may be useful for managing blood glucose levels in diabetic patients. Furthermore, by modifying the substrate specificity of glucose dehydrogenase to increase its reactivity to maltose, it becomes possible to obtain higher current values when using a fuel cell containing a mixture of glucose and maltose as fuel.
[0133] All references made herein are incorporated herein by reference in their entirety.
[0134] A brief explanation of arrays Sequence ID 1: GDH (MpGDH) derived from Mucor prainii aa Sequence ID 2 MpGDH gene DNA Sequence ID 3: Mucor RD056860 GDH(MrdGDH) aa Sequence ID 4 MrdGDH gene DNA
[0135] This disclosure includes the following sequence information. SEQUENCE LISTING <110> Kikkoman Corporation <120> A Method for modifying the substrate specificity of glucose dehydrogenase and glucose dehydrogenase substrate specificity modifying agent <130> P25-0061 <150> JP 2019-182592 <151> 2019-10-03 <150> JP 2019-058223 <151> 2019-03-26 <160> 4 <170> PatentIn version 3.5 <210> 1 <211> 641 <212> PRT <213> Mucor prainii <400> 1 Met Lys Ile Thr Ala Ala Ile Ile Thr Val Ala Thr Ala Phe Ala Ser 1 5 10 15 Phe Ala Ser Ala Gln Gln Asp Thr Asn Ser Ser Ser Thr Asp Thr Tyr 20 25 30 Asp Tyr Val Ile Val Gly Gly Gly Val Ala Gly Leu Ala Leu Ala Ser 35 40 45 Arg Ile Ser Glu Asn Lys Asp Val Thr Val Ala Val Leu Glu Ser Gly 50 55 60 Pro Asn Ala Asn Asp Arg Phe Val Val Tyr Ala Pro Gly Met Tyr Gly 65 70 75 80 Gln Ala Val Gly Thr Asp Leu Cys Pro Leu Ile Pro Thr Thr Pro Gln 85 90 95 Glu Asn Met Gly Asn Arg Ser Leu Thr Ile Ala Thr Gly Arg Leu Leu 100 105 110 Gly Gly Gly Ser Ala Ile Asn Gly Leu Val Trp Thr Arg Gly Gly Leu 115 120 125 Lys Asp Tyr Asp Ala Trp Glu Glu Leu Gly Asn Pro Gly Trp Asn Gly 130 135 140 Ala Asn Leu Phe Lys Tyr Phe Lys Lys Val Glu Asn Phe Thr Pro Pro 145 150 155 160 Thr Pro Ala Gln Ile Glu Tyr Gly Ala Thr Tyr Gln Lys Ser Ala His 165 170 175 Gly Lys Lys Gly Pro Ile Asp Val Ser Phe Thr Asn Tyr Glu Phe Ser 180 185 190 Gln Ser Ala Ser Trp Asn Ala Ser Leu Glu Thr Leu Asp Phe Thr Ala 195 200 205 Leu Pro Asp Ile Leu Asn Gly Thr Leu Ala Gly Tyr Ser Thr Thr Pro 210 215 220 Asn Ile Leu Asp Pro Glu Thr Val Gln Arg Val Asp Ser Tyr Thr Gly 225 230 235 240 Tyr Ile Ala Pro Tyr Thr Ser Arg Asn Asn Leu Asn Val Leu Ala Asn 245 250 255 His Thr Val Ser Arg Ile Gln Phe Ala Pro Lys Asn Gly Ser Glu Pro 260 265 270 Leu Lys Ala Thr Gly Val Glu Trp Tyr Pro Thr Gly Asn Lys Asn Gln 275 280 285 Lys Gln Ile Ile Lys Ala Arg Tyr Glu Val Ile Ile Ser Ser Gly Ala 290 295 300 Ile Gly Ser Pro Lys Leu Leu Glu Ile Ser Gly Ile Gly Asn Lys Asp 305 310 315 320 Ile Val Ser Ala Ala Gly Val Glu Ser Leu Ile Asp Leu Pro Gly Val 325 330 335 Gly Ser Asn Met Gln Asp His Val His Ala Ile Thr Val Ser Thr Thr 340 345 350 Asn Ile Thr Gly Tyr Thr Thr Asn Ser Val Phe Val Asn Glu Thr Leu 355 360 365 Ala Gln Glu Gln Arg Glu Glu Tyr Glu Ala Asn Lys Thr Gly Ile Trp 370 375 380 Ala Thr Thr Pro Asn Asn Leu Gly Tyr Pro Thr Pro Glu Gln Leu Phe 385 390 395 400 Asn Gly Thr Glu Phe Val Ser Gly Lys Glu Phe Ala Asp Lys Ile Arg 405 410 415 Asn Ser Thr Asp Glu Trp Ala Asn Tyr Tyr Ala Ser Thr Asn Ala Ser 420 425 430 Asn Val Glu Leu Leu Lys Lys Gln Tyr Ala Ile Val Ala Ser Arg Tyr 435 440 445 Glu Glu Asn Tyr Leu Ser Pro Ile Glu Ile Asn Phe Thr Pro Gly Tyr 450 455 460 Glu Gly Ser Gly Asn Val Asp Leu Gln Asn Asn Lys Tyr Gln Thr Val 465 470 475 480 Asn His Val Leu Ile Ala Pro Leu Ser Arg Gly Tyr Thr His Ile Asn 485 490 495 Ser Ser Asp Val Glu Asp His Ser Val Ile Asn Pro Gln Tyr Tyr Ser 500 505 510 His Pro Met Asp Ile Asp Val His Ile Ala Ser Thr Lys Leu Ala Arg 515 520 525 Glu Ile Ile Thr Ala Ser Pro Gly Leu Gly Asp Ile Asn Ser Gly Glu 530 535 540 Ile Glu Pro Gly Met Asn Ile Thr Ser Glu Asp Asp Leu Arg Ser Trp 545 550 555 560 Leu Ser Asn Asn Val Arg Ser Asp Trp His Pro Val Gly Thr Cys Ala 565 570 575 Met Leu Pro Lys Glu Leu Gly Gly Val Val Ser Pro Ala Leu Met Val 580 585 590 Tyr Gly Thr Ser Asn Leu Arg Val Val Asp Ala Ser Ile Met Pro Leu 595 600 605 Glu Val Ser Ser His Leu Met Gln Pro Thr Tyr Gly Ile Ala Glu Lys 610 615 620 Ala Ala Asp Ile Ile Lys Asn Phe Tyr Lys Thr Gln His Lys Asn Gln 625 630 635 640 Asn <210> 2 <211> 1926 <212> DNA <213> Mucor prainii <400> 2 atgaagatca cagctgccat tatcactgtt gccacagcat ttgcttcttt tgcttctgct 60 caacaagaca caaattcttc ctcaactgat acttatgatt atgttatcgt tggcggcggt 120 gtagctggtt tggctttggc tagtcgtatc tctgaaaaca aggatgtcac tgttgctgtt 180 ctcgagtccg gtcctaatgc caatgataga tttgttgttt atgctcctgg catgtatggc 240 caagctgttg gcactgatct ctgtcctctc attcctacta ctcctcaaga aaatatgggc 300 aacagaagtc tcacaatcgc tactggtaga ttgctcggtg gtggcagtgc tattaatggt 360 ctcgtttgga cccgtggtgg cttgaaggat tacgatgctt gggaggagct cggtaaccct 420 ggatggaacg gtgccaactt gttcaagtac tttaagaagg tcgaaaactt cactcctcct 480 actcctgccc aaattgaata cggcgctact tatcagaaaa gtgctcatgg caagaaggga 540 cctattgatg tctctttcac gaactacgag ttctctcaat ctgctagctg gaacgcctca 600 ctcgaaaccc ttgatttcac tgcacttcct gatatcttga acggtacttt ggccggttac 660 tctaccactc ccaacatttt ggaccctgag actgttcaac gtgttgattc ctatactggt 720 tacattgctc cttacactag ccgtaacaac ctcaatgttt tggccaacca taccgtctcc 780 cgcattcaat ttgctcccaa gaatggtagc gaacctctca aggctaccgg tgttgaatgg 840 tatccactg gcaacaagaa tcaaaagcaa attatcaagg cccgttatga agttatcatc 900 tcatctggtg ccattggtag tcctaagctt ttggaaatct ctggtatcgg taataaggat 960 atcgtctctg ctgctggtgt cgagtccttg attgacttgc ctggcgttgg ttccaacatg 1020 caagatcacg ttcatgctat cactgtctct actaccaata ttactggcta tactaccaac 1080 agcgtctttg tcaatgaaac ccttgcccaa gaacaaagag aagaatatga agccaacaag 1140 actggtatct gggctactac tcccaacaac ctcggttatc ctacgcccga acaactcttc 1200 aatggcaccg aattcgtttc tggaaaggag tttgctgaca agattcgtaa ctctactgat 1260 gaatgggcca actattatgc ttccaccaac gcctccaatg tcgagttatt aaagaagcaa 1320 tatgctattg tcgcctctcg ttacgaagag aactacttgt ctcctattga aatcaacttc 1380 actcctggtt atgagggtag cggtaatgtc gatttgcaaa acaacaagta ccaaactgtc 1440 aaccatgtct tgattgctcc tttaagtcgt ggttatactc acattaactc ttctgatgtg 1500 gaggatcatt ctgtcattaa tccccaatac tactctcatc ctatggatat tgatgtccat 1560 atcgcttcca ctaaacttgc tcgcgaaatc atcactgcct ctcccggtct tggtgacatt 1620 aacagtggcg aaatcgaacc cggtatgaat attacttctg aagacgacct tagatcttgg 1680 ttgagtaata atgtccgttc tgactggcat cctgttggta cttgtgctat gcttcccaag 1740 gaattaggtg gtgttgtcag ccccgctctc atggtttacg gcacttccaa cttgcgtgtt 1800 gttgatgctt cgattgcc cctcgaagtc tcttctcatt tgatgcacc cacctacggt 1860 attgctgaga aggctgctga cattattag aatttctaca agactcaca CAGAACCA 1920 Attack 1926 <210> 3 <211> 631 <212> PRT <213> Mucor RD056860 <400> 3 Met Arg Leu Ser Val Ala Ser 1 5 10 15 Val Thr Will Be Only Gln Gln Asn Asn Thr Asp Thr Tyr Asp Tyr Val Ile 20 25 30 Val Gly Gly Gly Val Gly Gly Leu Ala Leu Ala Ser Arg Leu Ser Glu 35 40 45 Asp Lys Asn Val Thr Val Ala Val Leu Glu Ser Gly Pro Tyr Ala Asp 50 55 60 Asp Lys Phe Val Val Tyr Ala Pro Gly Met Tyr Gly Gln Ala Val Gly 65 70 75 80 Thr Asp Leu Cys Pro Leu Leu Pro Thr Val Pro Gln Pro Ser Met Asn 85 90 95 Asn Arg Thr Ile Thr Ile Ala Thr Gly Arg Leu Leu Gly Gly Gly Ser 100 105 110 Ala Val Asn Gly Leu Val Trp Thr Arg Gly Ala Met Lys Asp Phe Asp 115 120 125 Ala Trp Gln Glu Leu Gly Asn Pro Gly Trp Asn Gly Thr Thr Met Phe 130 135 140 Lys Tyr Phe Lys Lys Ile Glu Asn Phe His Pro Pro Thr Glu Glu Gln 145 150 155 160 Ile Gln Tyr Gly Ala Thr Tyr Asn Lys Ser Val His Gly Phe Asn Gly 165 170 175 Pro Ile Asp Ile Ala Phe Pro Val Phe Glu Phe Pro Gln Ser Ala Asn 180 185 190 Trp Asn Ala Ser Leu Ala His Leu Asn Phe Thr Arg Arg Gln Asp Leu 195 200 205 Leu Asp Gly Ser Leu His Gly Tyr Ser Thr Thr Pro Asn Thr Leu Asn 210 215 220 Pro Gln Thr Ala Arg Arg Ala Asp Ala Tyr Ala Gly Tyr Ile Gln Pro 225 230 235 240 Asn Val Asn Arg Thr Asn Leu Ala Val Leu Ala Asn His Thr Val Ser 245 250 255 Arg Ile Gln Phe Glu Ala Arg Asn Gly Ser Gln Pro Leu Lys Ala Ile 260 265 270 Gly Val Glu Trp Tyr Thr Thr Gly Gly Asp Lys Thr Ser Lys Gln Thr 275 280 285 Ile Lys Ala Arg Arg Glu Ile Ile Leu Ser Ser Gly Ala Ile Gly Ser 290 295 300 Pro Lys Leu Leu Glu Val Ser Gly Ile Gly Asn Lys Ala Ile Val Thr 305 310 315 320 Ala Ala Gly Val Gln Ser Leu Ile Asp Leu Pro Gly Val Gly Ser Asn 325 330 335 Met Gln Asp His Val His Ala Val Thr Val Ser Thr Thr Asn Ile Asp 340 345 350 Gly Tyr Thr Thr Asn Ser Val Phe Thr Asn Glu Thr Leu Ala Gln Glu 355 360 365 Gln Lys Asp Leu Tyr Tyr Asn Asn Lys Thr Gly Ile Trp Thr Thr Thr 370 375 380 Pro Asn Asn Leu Gly Tyr Pro Ser Pro Ser Gln Leu Phe Thr Asn Thr 385 390 395 400 Thr Phe Lys Ser Gly Lys Glu Phe Ala Ala Met Ile Arg Asn Ser Thr 405 410 415 Asp Lys Tyr Ala Gln Tyr Tyr Ala Ala Asn Asn Ala Thr Asn Val Glu 420 425 430 Leu Leu Lys Lys Gln Tyr Ser Ile Val Ala Arg Arg Tyr Glu Glu Asn 435 440 445 Tyr Ile Ser Pro Ile Glu Ile Asn Phe Thr Pro Gly Tyr Gly Gly Thr 450 455 460 Gly Met Ala Asp Leu Gln Asn Lys Lys Tyr Gln Thr Val Asn His Val 465 470 475 480 Leu Val Ala Pro Leu Ser Arg Gly Tyr Thr His Ile Asn Ser Ser Asp 485 490 495 Ile Glu Asp Pro Val Val Ile Asp Pro Gln Tyr Tyr Ser His Pro Leu 500 505 510 Asp Val Asp Val His Val Ala Ser Thr Gln Leu Ala Arg Ser Ile Leu 515 520 525 Asn Ala Pro Gly Leu Ala Ser Ile Asn Ser Gly Glu Val Glu Pro Gly 530 535 540 Glu Lys Val Gln Ser Asp Glu Asp Val Arg Lys Trp Leu Ser Asp Asn 545 550 555 560 Val Arg Ser Asp Trp His Pro Val Gly Thr Cys Ala Met Leu Pro Arg 565 570 575 Lys Leu Gly Gly Val Val Asp Ser Lys Leu Lys Val Tyr Gly Thr Ala 580,585,590 Asn Leu Arg Ile Val Asp Ala Ser Ile Ile Pro Leu Glu Ile Ser Ser 595,600,605 His Leu Met Gln Pro Val Tyr Ala Val Ser Glu Arg Ala Ala Asp Ile 610 615 620 Ile Lys Dear Dear Dear Lys Lys 625 630 <210> 4 <211> 1896 <212> DNA <213> Artificial <220> <223> synthetic <400> 4 atgcgtctct ctgtggcgat cctcactctc acttcggctc tgcttcggt tacctcggcc 60 caacaaaaca atactgatac ttatgactac gtgatcgtcg gaggaggagt gggtggactg 120 gctctcgctt cgcgcctc cgaggataag aacgttaccg tgctgtcct ggaatcgggc 180 ccttatgcgg atgacaaatt cgtggtctac gccccaggga tgtatggtca ggctgtcgga 240 actgacctgt gtcctctgct cccaacggtt cctcaaccat ctatgaacaa tcgaaccatc 300 actattgcta cgggacgtct gctcggagga ggttcagctg tgaacggact ggtctggacc 360 cgtggagcta tgaaggattt cgacgcttgg caggagctgg gaaacccagg atggaatggg 420 accactatgt tcaagtactt caagaaaatc gaaaacttcc atcccccgac cgaggaacag 480 attcaatacg gcgctactta taacaagtct gtccacggtt tcaatggccc gatcgatatt 540 gcctttcccg tgttcgagtt tccgcagtct gctaactgga atgcgtcact ggcccatctc 600 aacttcaccc gccggcaaga tctgctcgac ggtagtctcc acggctacag cacgacccct 660 aacaccctga atccacagac tgcccgacgt gcggatgcct acgctggata tatccaacct 720 aacgtcaatc gaacgaacct ggctgtcctc gcgaatcata ccgttagtcg catccagttt 780 gaggcgcgga acggtagcca accactgaag gccattggcg tggaatggta tactacggggc 840 gagachaga ctagtaaca gacgatcaag gcgcgccgggg agatcattct gagtagcgga 900 gccattgggt cgcctaagct gctcgaagtg tccgggatcg gtaacaaagc cattgttacc 960 gccgctggag tgcagtctct gatcgatctc ccaggcgttg gatcaacat gcaagaccat 1020 gtgcacgctg ttaccgtgtc gaccactaat atcgatgggt acacgaccaa ctccgtgttc 1080 acaatgaga ccctcgccca ggcaaaag gacctgtact acaacaa gactggaatc 1140 tggactacga cccctaacaa tctcggtat cccagtccga gccagctgtt caccacact 1200 acgtttaagt ctggcaaaga gtttgcggcc atgatccgca acagtactga taagtacgcc 1260 cagtactatg ctgcgaacaa tgctacgaac gtcgagctgc tcagaaca atatagtatc 1320 gtggcccgac gttacgagga aaactacatc agcctacg aaatcaactt cacgccagga 1380 tacgggggta ccgggatggc tgatctgcag aacaagaaat atcaaaccgt gaatcatgtc 1440 ctggttgccc ccctcagtcg gggctacact cacatcaact cgtccgatat tgaggacccc 1500 gttgtgatcg acccgcagta ctatagccat ccgctggatg tggacgtcca cgttgcgagt 1560 acccaactgg cccgaagcat cctcaacgcc cccggactgg cttctattaa ttcaggcgag 1620 gtggaaccgg gcgagaaggt ccagagcgat gaagacgttc gcaaatggct gtcggataac 1680 gtgcgttccg actggcatcc agtcggaacc tgcgctatgc tgccacgaaa gctcggagga 1740 gtcgttgatt cgaagctcaa agtctacggc accgcgaatc tgcgtatcgt tgacgcctcc 1800 atcattccgc tcgagatttc ttcacacctg atgcaaccag tctatgcggt ctccgaacgg 1860 gctgccgaca tcatcaaatc ctcctctaaa aaataa 1896
Claims
1. A glucose dehydrogenase substrate specificity modifier comprising one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, ribitol, D-mannitol, xylitol, and glycerol, wherein the modifier is a low molecular weight compound that is an analog of glucose, and the ratio of the reactivity of FAD-dependent glucose dehydrogenase (FAD-GDH) to glucose (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of the glucose dehydrogenase to maltose (Mal) to glucose (Glu) (Mal / Glu) in the absence of the modifier; and a glucose measurement composition or glucose measurement reagent comprising glucose dehydrogenase derived from the genus Mucor or Aspergillus, for measuring a sample containing maltose.
2. A glucose measurement composition or glucose measurement reagent according to claim 1, comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase as separate reagents.
3. The glucose measurement composition or glucose measurement reagent according to claim 1, comprising a glucose dehydrogenase substrate specificity modifier and glucose dehydrogenase in the same reagent.
4. A glucose dehydrogenase substrate specificity modifier comprising one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, ribitol, D-mannitol, xylitol, and glycerol, wherein the modifier is a low molecular weight compound that is an analog of glucose, and the ratio of the reactivity of FAD-dependent glucose dehydrogenase (FAD-GDH) to glucose (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of FAD-GDH to glucose (Mal / Glu) in the absence of the modifier; and a glucose measurement system comprising glucose dehydrogenase derived from the genus Mucor or Aspergillus immobilized on a solid phase surface, for measuring a sample containing maltose.
5. A glucose dehydrogenase substrate specificity modifier comprising one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, ribitol, D-mannitol, xylitol, and glycerol, wherein the modifier is a low molecular weight compound that is an analog of glucose, and the ratio of the reactivity of FAD-dependent glucose dehydrogenase (FAD-GDH) to glucose (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of FAD-GDH to glucose (Mal / Glu) in the absence of the modifier; and a glucose measurement system comprising glucose dehydrogenase derived from the genus Mucor or Aspergillus that is not immobilized on a solid phase surface, for measuring a sample containing maltose.
6. A method for measuring glucose using the composition or reagent described in claim 1, 2, or 3, or the system described in claim 4 or 5.
7. An electrode for electrochemically measuring a sample containing maltose, comprising a glucose dehydrogenase substrate specificity modifier and FAD-dependent glucose dehydrogenase (FAD-GDH) derived from the genus Mucor or Aspergillus, wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, ribitol, D-mannitol, xylitol, and glycerol, and the electrode modifies the ratio of the reactivity of the glucose dehydrogenase (FAD-GDH) to maltose (Mal) to glucose (Glu) (Mal / Glu) in the presence of the modifier, compared to the ratio of the reactivity of the glucose dehydrogenase (FAD-GDH) to maltose (Mal) to glucose (Glu) (Mal / Glu) in the absence of the modifier.
8. A battery for using a maltose-containing fuel, comprising a glucose dehydrogenase substrate specificity modifier and FAD-dependent glucose dehydrogenase (FAD-GDH) derived from the genus Mucor or Aspergillus, wherein the glucose dehydrogenase substrate specificity modifier comprises one or more compounds selected from the group consisting of sorbitol, D-iditol, L-iditol, ribitol, D-mannitol, xylitol, and glycerol, and the ratio of the reactivity of the glucose dehydrogenase (FAD-GDH) to maltose (Mal) to glucose (Glu) (Mal / Glu) in the presence of the modifier is modified compared to the ratio of the reactivity of the glucose dehydrogenase (FAD-GDH) to maltose (Mal) to glucose (Glu) (Mal / Glu) in the absence of the modifier.
Citation Information
Patent Citations
Kogatadenshikeisankino chisuteiseihoshiki
JP1976076045A
Method of producing solid electrolytic condenser
JP1986001011A
Robot controller
JP1989002887A
Method of measuring glucose in blood, and sensor used therefor
JP2005114359A
Method for enhancing stability of composition comprising soluble glucose dehydrogenase (GDH)
JP2009195250A
